Previous Article | Next Article ![]()
Infection and Immunity, January 1999, p. 421-422, Vol. 67, No. 1
Department of Biological Chemistry, Weizmann
Institute of Science, Rehovot 76100, Israel
Received 20 July 1998/Returned for modification 23 September
1998/Accepted 28 October 1998
Trophozoites of virulent Entamoeba histolytica
transfected with the antisense gene encoding cysteine proteinase 5 (CP5) have only 10% of the CP activity but retain their cytopathic
activity on mammalian monolayers. In the present study we found that
the transfected trophozoites with low levels of CP activity were
incapable of inducing the formation of liver lesions in hamsters.
Several cysteine proteinases (CP)
with molecular masses in the range of 16 to 96 kDa have been detected
in trophozoite extracts of pathogenic Entamoeba histolytica
strains (9, 12, 15). CP are considered an important
virulence factor in the pathogenesis of amebiasis and have been
suggested to play a key role in tissue invasion, disruption of host
tissues, and modulation of the cell-mediated immune response (4,
12-14). Bruchhaus and colleagues have identified up to six
different CP genes which encode typical papain family proteinases with
a high degree of conservation in all active site residues
(3). One of them, CP5, was found to be associated with the
trophozoite membranes and has been suggested to have a potential role
in host tissue destruction. Interestingly, the gene encoding CP5
(cp5) is missing in the closely related but nonpathogenic
species Entamoeba dispar (7). Recently, we have generated a transfectant of E. histolytica HM-1:IMSS in
which the transcribed cp5 antisense RNA (E. histolytica HM-1:IMSS pSA8 transfectant) strongly reduces the
expression of CP (2). In spite of their low levels of CP
activity, the pSA8 transfectants are, however, not impaired in their
ability to destroy tissue culture monolayers (cytopathic activity). On
the other hand, pSA8 transfectants have significantly lower
erythrophagocytosis activity than does the parental strain
(2).
In this study we examined the ability of the E. histolytica
HM-1:IMSS pSA8 transfectant to induce the formation of liver abscesses in hamsters. The level of CP in detergent lysates of pSA8 trophozoites grown in the presence of 60 µg of G418 per ml was determined, prior
to intrahepatic inoculation into the hamsters, by monitoring the
digestion of the fluorogenic substrate Z-Arg-Arg-pNA (8). The total CP activity in lysates of the pSA8 transfectant was approximately 10% of the level of CP activity determined in the control lysates of the pEhAct-Neo (1) transfectant. The
generation times of the two transfected trophozoite cultures
(pEhAct-Neo and pSA8) grown in TYI-S-33 medium (5) in the
presence of 60 µg of G418 per ml and the nontransfected parental
HM1:IMSS strain were 8 and 7 h, respectively. This difference is
most likely due to some inhibitory effects of the neomycin derivative
G418. Syrian golden hamsters (6 weeks old) were intrahepatically
inoculated (18) with 106 trophozoites from the
following cultures: (i) E. histolytica HM-1:IMSS pSA8 grown
in the presence of 60 µg of G418 per ml, (ii) E. histolytica HM-1:IMSS pEhAct-Neo grown in the presence of 60 µg
of G418 per ml, and (iii) E. histolytica HM-1:IMSS
nontransfected trophozoites. Hamsters (eight in each group) were
sacrificed 1 week after intrahepatic inoculation, and the formation
of lesions was evaluated (Table 1). All
eight hamsters injected with E. histolytica HM-1:IMSS
trophozoites as well as those inoculated with the HM-1:IMSS
pEhAct-Neo transfectant presented extensive necrotic lesions. The
sizes of the lesions obtained with HM-1:IMSS trophozoites were larger
(>2 cm) than those obtained with HM1:IMSS pEhAct-Neo (1 to 2 cm). The
smaller size may be due to the above-mentioned difference in growth
rates. Only one of the eight hamsters injected with the HM-1:IMSS pSA8
transfectant presented a small isolated lesion, whereas none of the
others had any detectable hepathic lesions. A section of
amoeba-infected liver was inoculated under sterile conditions in
TYI-S-33 medium. For lesions obtained with the E. histolytica HM-1:IMSS trophozoites and the HM-1:IMSS pEhAct-Neo transfectant, a full trophozoite culture was obtained 24 h after inoculation into the TYI-S-33 medium in the absence of G418. For the
small and isolated lesion obtained with the E. histolytica HM-1:IMSS pSA8 transfectant, it took 2 weeks to get a satisfactory culture of trophozoites in the absence of G418. Plasmid DNA was rescued
from pSA8- and pEhAct-Neo-transfected trophozoites and introduced into
Escherichia coli cells to yield ampicillin-resistant transfectants, showing that in both cases the plasmid was still present
in trophozoites recovered from liver abscess (Fig.
1). As a control, we were also able to
rescue pSA8 and pEhAct-Neo plasmid from transfected trophozoites
initially grown in TYI-S-33 medium in the presence of 60 µg of G418
per ml and then cultivated for 2 weeks in TYI-S-33 medium in the
absence of G418 (Fig. 1). Interestingly, lysates of pSA8-transfected
amoebae that were recovered from the single abscess had 35% of the
level of CP activity found in pEhAct-Neo-transfected
trophozoites. This level of CP activity is slightly higher than the
level of CP activity (10%) found in pSA8-transfected
trophozoites before their passage through the livers of hamsters as
demonstrated in this study as well as in our previous study
(2). This result could be due to selection in the liver of a subpopulation of pSA8-transfected trophozoites that have slightly higher CP activity. The selection of amoeba clones with higher levels of CP activity by hamster liver passages was
previously reported by Navarro-Garcia et al. (10).
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Antisense Inhibition of Expression of Cysteine
Proteinases Affects Entamoeba histolytica-Induced
Formation of Liver Abscess in Hamsters
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Hamster liver abscess formation by
transfected trophozoites

View larger version (85K):
[in a new window]
FIG. 1.
Restriction analysis of plasmid rescued in E. coli XL1-blue from pEhAct-Neo- and pSA8-transfected trophozoites
isolated from liver abscess. Plasmid preparations were digested by
restriction enzymes (XhoI-SalI) and size
fractionated on agarose gels. Lanes: 1, plasmid pEhAct-Neo; 2, plasmid
pSA8; 3, plasmid rescued from pEhAct-Neo transfectant isolated from
liver abscess; 4, plasmid rescued from pSA8 transfectant isolated from
liver abscess; 5, plasmid rescued from pEhAct-Neo transfectant
cultivated in TYI-S-33 medium for 2 weeks in the absence of G418; and
6, plasmid rescued from pSA8 transfectant cultivated in TYI-S-33 medium
for 2 weeks in the absence of G418.
Our results suggest an important role for amoeba CP in liver abscess formation in hamsters. This conclusion is in agreement with the results observed upon inhibition of CP by the specific inhibitor E-64 and reduction of liver abscess formation in SCID mice (17). Our present results clearly indicate that the in vitro cytopathic assay is not sufficiently indicative of ameobic virulence. In our previous study with tissue-cultured monolayers, we demonstrated that in contrast to intact trophozoites, lysates of the pSA8-transfected trophozoites had very poor cytolytic activity. These findings indicate that while intact trophozoite CP are not a main factor for destruction of monolayers, CP most likely play an important role in the mammalian liver where ameobae must battle the immunological defenses of the host (16). Based on the differences that we find between the in vitro and in vivo determinations of transfectant virulence, the presence and release of CP by intact and lysed ameoba are important in vivo components involved in tissue damage in the host. Other elements involved in ameobic virulence are resistance to complement and phagocytosis activity. It has been shown that after long-term cultivation in vitro pathogenic isolates were susceptible to lysis by the alternative pathway of complement (6). No significant difference was found in the susceptibility of pSA8 transfectants and that of the pEhAct-Neo control or untransfected strain HM-1:IMSS to complement. In all cases lysis was approximately ±70%. Another aspect that may also be of importance is the impaired rate of erythrophagocytosis of the pSA8 transfectants (2), which could also contribute to its inability to induce liver abscesses. However, in view of the conflicting reports about the correlation between the phatocytic activity of the trophozoites and their ability to induce liver abscesses (11, 19), more studies are needed for conclusions about the involvement of phagocytic activity in the formation of liver abscesses.
| |
ACKNOWLEDGMENTS |
|---|
S. Ankri was supported by a Feinberg Graduate School postdoctoral fellowship (Weizmann Institute). This work was supported in part by the Leo and Julia Forchheimer Center for Molecular Genetics at the Weizmann Institute of Science and the Center for the Study of Emerging Diseases.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel. Phone: 972-8-9343160. Fax: 972-8-9468256. E-mail: bfmirelm{at}weizmann.weizmann.ac.il.
Editor: P. J. Sansonetti
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alon, R., R. Bracha, and D. Mirelman. 1997. Inhibition of expression of the lysine-rich 30 kDa surface antigen of Entamoeba dispar by the transcription of its antisense RNA. Mol. Biochem. Parasitol. 90:193-201[Medline]. |
| 2. | Ankri, S., T. Stolarsky, and D. Mirelman. 1998. Antisense inhibition of expression of cysteine proteinases in Entamoeba histolytica does not affect cytopathic or hemolytic activity but inhibits phagocytosis. Mol. Microbiol. 28:777-785[Medline]. |
| 3. | Bruchhaus, I., T. Jacobs, M. Leippe, and E. Tannich. 1996. Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinases genes. Mol. Microbiol. 22:255-263[Medline]. |
| 4. | Campell, D., and K. Chadee. 1997. Survival strategies of Entamoeba histolytica: modulation of cell-mediated immune response. Parasitol. Today 13:184-190. |
| 5. | Diamond, L. S., D. R. Harlow, and C. C. Cunnick. 1978. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans. R. Soc. Trop. Med. Hyg. 72:431-432[Medline]. |
| 6. | Hamelmann, C., B. Foerster, G. D. Burchard, and R. D. Horstmann. 1992. Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysis. Parasite Immunol. 14:23-35[Medline]. |
| 7. | Jacobs, T., I. Bruchhaus, T. Dandekar, E. Tannich, and M. Leippe. 1998. Isolation and molecular characterization of a surface-bound proteinase of Entamoeba histolytica. Mol. Microbiol. 27:269-276[Medline]. |
| 8. | Leippe, M. 1995. Spontaneous release of cysteine proteinases but not of pore-forming peptides by viable Entamoeba histolytica. Parasitology 111:569-574. |
| 9. | Luaces, A. L., and A. J. Barrett. 1988. Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica. Biochem. J. 250:903-909[Medline]. |
| 10. | Navarro-Garcia, F., L. Chavez-Duenas, V. Tsutsumi, F. Posadas del Rio, and R. Lopez-Revilla. 1995. Entamoeba histolytica: increase of enterotoxicity and of 53- and 75-kDa cysteine proteinases in a clone of higher virulence. Exp. Parasitol. 80:361-372[Medline]. |
| 11. | Orozco, E., M. E. Suarez, and T. Sanchez. 1985. Differences in adhesion, phagocytosis and virulence of clones from Entamoeba histolytica, strain HM1:IMSS. Int. J. Parasitol. 15:655-660[Medline]. |
| 12. | Que, X., and S. L. Reed. 1997. The role of extracellular cysteine proteinases in pathogenesis of Entamoeba histolytica invasion. Parasitol. Today 13:190-194. |
| 13. | Ravdin, J. I. 1988. Human infection by Entamoeba histolytica, p. 166-176. In J. I. Ravdin (ed.), Amebiasis: human infection. John Wiley, New York, N.Y. |
| 14. | Reed, S., J. Bouvier, A. S. Pollack, J. C. Engel, M. Brown, K. Hirata, X. Que, A. Eakin, P. Hagblom, F. Gillin, et al. 1993. Cloning of a virulence factor of Entamoeba histolytica. J. Clin. Invest. 91:1532-1540. |
| 15. |
Scholze, H.,
S. Frey,
Z. Cejka, and T. Bakker-Grunwald.
1996.
Evidence for the existence of both proteasomes and a novel high molecular weight peptidase in Entamoeba histolytica.
J. Biol. Chem.
271:6212-6216 |
| 16. | Shibayama, M., R. Campos-Rodriguez, A. Ramirez-Rosales, L. Flores-Romo, M. Espinosa-Cantellano, A. Martinez-Palomo, and V. Tsutsumi. 1998. Entamoeba histolytica: liver invasion and abscess production by intraperitoneal inoculation of trophozoites in hamsters. Exp. Parasitol. 88:20-27[Medline]. |
| 17. | Stanley, S. L., Jr. 1995. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect. Immun. 63:1587-1590[Abstract]. |
| 18. | Tsutsumi, V., R. Mena-López, F. Anaya-Velázquez, and A. Martinez-Palomo. 1984. Cellular bases of experimental amebic liver abscess formation. Am. J. Pathol. 117:81-91[Abstract]. |
| 19. | Tsutsumi, V., A. Ramirez-Rosales, H. Lanz-Mendoza, M. Shibayama, B. Chavez, E. Rangel-Lopez, and A. Martinez-Palomo. 1992. Entamoeba histolytica: erythrophagocytosis, collagenolysis, and liver abscess production as virulence markers. Trans. R. Soc. Trop. Med. Hyg. 86:170-172[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|